Now, the Franklin Lakes, NJ-based company is targeting Monkeypox through a new collaboration with CerTest BioTec. The two will develop a molecular diagnostic test for the Monkeypox virus. As part of the collaboration, the assay will use the BD MAX open system reagent suite to validate the CerTest Viasure Monkeypox CE/IVD molecular test on the BD MAX System. The assay will be available for BD MAX users and may help advance understanding of the global spread of the disease. "Through our collaboration with CerTest and their ability to rapidly transfer assays on the BD MAX System, we will enable BD MAX System users around the world to access a test for the confirmation of monkeypox."

Source: The North Africa Journal June 08, 2022 15:34 UTC